共 101 条
- [1] Bjurberg M(2006)FDG-PET in the detection of residual disease and relapse in patients with Hodgkin's lymphoma. Experience from a Swedish centre Acta Oncol 45 743-749
- [2] Gustavsson A(2001)Comparison of 18FDG-PET with CT scans in the evaluation of patients with residual and recurrent Hodgkin's lymphoma Oncol Rep 8 1393-1399
- [3] Ohlsson T(2002)Annual report to the nation on the status of cancer, 1973-1999, featuring implications of age and aging on U.S. cancer burden Cancer 94 2766-2792
- [4] Brun E(2009)Evidence-based approach to the introduction of positron emission tomography in ontario, Canada J Clin Oncol 27 5607-5613
- [5] Dittmann H(2007)Diagnostic and prognostic value of 18F-FDG PET/CT for patients with suspected recurrence from squamous cell carcinoma of the esophagus J Nucl Med 48 1251-1258
- [6] Sokler M(2005)Evaluation of integrated whole-body PET/CT in the detection of recurrent ovarian cancer Eur J Radiol 56 263-268
- [7] Kollmannsberger C(2008)Impact of positron emission tomography/computed tomography and positron emission tomography (PET) alone on expected management of patients with cancer: initial results from the national oncologic PET registry J Clin Oncol 26 2155-2161
- [8] Dohmen BM(2013)Intended J Nucl Med 54 2024-2031
- [9] Baumann C(2005) inferred care after PET performed for initial staging in the National Oncologic PET Registry Breast Cancer Res Treat 90 105-112
- [10] Kopp A(2007)A meta-analysis of FDG-PET for the evaluation of breast cancer recurrence and metastases J Nucl Med 48 28S-35S